The metabolic syndrome (MS) represents a cluster of cardiovascular (CV) risk factors associated to CV disease and type 2 diabetes. It is still under debate whether MS is a mere aggregation of risk factors or it represents a clinical entity with visceral obesity as underlying pathophysiological trigger. The publication of several diagnostic criteria of MS by scientific associations or experts panels reflects this uncertainty in understanding the real nature of MS. Besides the metabolic disturbances of MS, as visceral obesity, hypertriglyceridemia, low HDL cholesterol, hypertension and hyperglycemia, novel mechanisms of arterial damage have been identified. This paper reviews the evidence showing that MS and MS factors are characterized by increased oxidative stress, a relevant factor contributing to the development of metabolic and cardiovascular complications. In the next future, the measure of plasma oxidative stress may contribute to identify a subset of MS patients at increased CV risk, candidates to more intensive therapies.

Hopps, E., Noto, D., Caimi, G., Averna, M. (2010). A novel component of the metabolic syndrome : The oxidative stress. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 20(1), 72-77 [10.1016/j.numecd.2009.06.002].

A novel component of the metabolic syndrome : The oxidative stress

HOPPS, Eugenia;NOTO, Davide;CAIMI, Gregorio;AVERNA, Maurizio
2010-01-01

Abstract

The metabolic syndrome (MS) represents a cluster of cardiovascular (CV) risk factors associated to CV disease and type 2 diabetes. It is still under debate whether MS is a mere aggregation of risk factors or it represents a clinical entity with visceral obesity as underlying pathophysiological trigger. The publication of several diagnostic criteria of MS by scientific associations or experts panels reflects this uncertainty in understanding the real nature of MS. Besides the metabolic disturbances of MS, as visceral obesity, hypertriglyceridemia, low HDL cholesterol, hypertension and hyperglycemia, novel mechanisms of arterial damage have been identified. This paper reviews the evidence showing that MS and MS factors are characterized by increased oxidative stress, a relevant factor contributing to the development of metabolic and cardiovascular complications. In the next future, the measure of plasma oxidative stress may contribute to identify a subset of MS patients at increased CV risk, candidates to more intensive therapies.
2010
Hopps, E., Noto, D., Caimi, G., Averna, M. (2010). A novel component of the metabolic syndrome : The oxidative stress. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 20(1), 72-77 [10.1016/j.numecd.2009.06.002].
File in questo prodotto:
File Dimensione Formato  
A novel component of the metabolic syndrome.pdf

Solo gestori archvio

Descrizione: Articolo principale
Dimensione 176.62 kB
Formato Adobe PDF
176.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/46812
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 300
  • ???jsp.display-item.citation.isi??? 268
social impact